Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies (Q84696507)
Jump to navigation
Jump to search
scientific article published on 30 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies |
scientific article published on 30 July 2012 |
Statements
Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies (English)
James F Sigafoos
Gary D Bowers
Stephen Castellino
Amanda G Culp
David S Wagner
Melinda J Reese
Joan E Humphreys
Elizabeth K Hussey
Robin L O'Connor Semmes
Anita Kapur
Wenli Tao
Robert L Dobbins